Calcified Tissue International

, Volume 69, Issue 4, pp 242–247

Risedronate Increases Bone Density and Reduces Vertebral Fracture Risk Within One Year in Men on Corticosteroid Therapy

  • D.M. Reid
  • S. Adami
  • J.-P. Devogelaer
  • A.A. Chines
Article

DOI: 10.1007/s00223-001-1060-8

Cite this article as:
Reid, D., Adami, S., Devogelaer, JP. et al. Calcif Tissue Int (2001) 69: 242. doi:10.1007/s00223-001-1060-8

Copyright information

© Springer-Verlag New York Inc. 2001

Authors and Affiliations

  • D.M. Reid
    • 1
  • S. Adami
    • 2
  • J.-P. Devogelaer
    • 3
  • A.A. Chines
    • 4
  1. 1.University of Aberdeen, Medical School Buildings, Foresterhill, Aberdeen, AB25 22D, UKUK
  2. 2.Clinicizzato di Valeggio, Valeggio, ItalyItaly
  3. 3.Louvain Catholic University, Brussels, BelgiumBelgium
  4. 4.Procter & Gamble Pharmaceuticals, Cincinnati, Ohio, USAUSA